Influence of co-administered antibiotics on the pharmacokinetic fate in rats of paeoniflorin and its active metabolite paenimetabolin-1 from Shaoyao-Gancao-tang

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 3, 2003, Pages 313-321

  He, Ju Xiu ^a   Akao, Teruaki ^a   Tani, Tadato ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; METRONIDAZOLE; OFLOXACIN; PAEONIFLORIN; PAEONIMETABOLIN 1; PLANT EXTRACT; SHAOYAO GANCAO TANG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG ELIMINATION; DRUG FORMULATION; DRUG POTENTIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLORA; MALE; MONOTHERAPY; NONHUMAN; PHARMACOKINETICS; RAT; SINGLE DRUG DOSE; TREATMENT OUTCOME; TREATMENT PLANNING;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BENZOIC ACIDS; BIOTRANSFORMATION; BRIDGED COMPOUNDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; FECES; GLUCOSIDES; MALE; MEDICINE, KAMPO; METRONIDAZOLE; OFLOXACIN; PENICILLINS; RATS; RATS, WISTAR;

EID: 0346664382     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702748     Document Type: Article

References (30)

1. Abdel-Hafez, A. A., Meselhy, M. R.,Nakamura, N., Hattori, M., Watanabe, H., Murakami, Y., El-Gendy, M. A., Mahfouz, N. M., Mohamed, T. A. (1999) Anticonvulsant activity of paeonimetabolin-I adducts obtained by incubation of paeoniflorin and thiol compounds with Lactobacillus brevis. Biol. Pharm. Bull. 22: 491-497
2. Alam, A. N., Saha, J. R., Dobkin, J. F., Lindenbaum, J. (1988) Interethnic variation in the metabolic inactivation of digoxin by the gut flora. Gastroenterology 95: 117-123
3. Aldridge, K. E., Sanders, C. V., Lewis, A. C., Marier, R. L. (1983) Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production. J. Med. Microbiol. 16: 75-82
4. Bailer, A. J. (1988) Testing for the equality of area under the curves when using destructive measurement techniques. J. Pharmacokinet. Biopharm. 16: 303-309
5. Bando, M., Shibahara, N., Shimada, Y., Meselhy, M. R., Akao, T., Itoh, T., Terasawa, K. (2000) Pharmacokinetic study of paeoniflorin, paeonimetabolin-I and glycyrrhetic acid in humans after oral administration of Paeony root, Glycyrrhiza and Shakuyaku-Kanzo-To (Shao-Yao-Gan-Cao-Tang). J. Trad. Med. 17: 26-33
6. Chen, L.-C., Chou, M.-H., Lin, M.-F., Yang, L.-L. (2002) Pharmacokinetics of paeoniflorin after oral administration of Shao-yao Gan-chao tang in mice. Jpn. J. Pharmacol. 88: 250-255
7. Csizmadia, F., Endrenyi, L. (1998) Model-independent estimation of lag times with first-order absorption and disposition. J. Pharm. Sci. 87: 608-612
8. Drew, R. H., Gallis, H. A. (1988) Ofloxacin: Its pharmacology, pharmacokinetics, and potential for clinical application. Pharmacotherapy 8: 35-46
9. Gibaldi, M., Perrier, D. (1982) Pharmacokinetics, 2nd edn. Marcel Dekker, New York
10. Hasegawa, T., Yamaki, K., Muraoka, I., Nadai, M., Takagi, K., Nabeshima, T. (1995) Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin. Antimicrob. Agents Chemother. 39: 2135-2137
11. Hattori, M., Yang, X.-W., Shu, Y.-Z., Heikal, O. A., Miyashiro, H., Kato, H., Kanaoka, M., Akao, T., Kabashi, K., Namba, T. (1996) Enzyme immunoassay for paeonimetabolin I, a major metabolite of paeoniflorin by intestinal bacteria. J. Trad. Med. 13: 73-80
12. He, J.-X., Akao, T., Nishino, T., Tani, T. (2001) The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancaotang. Biol. Pharm. Bull. 24: 1395-1399
13. He, J.-X., Akao, T., Tani, T. (2002) Development of a simple HPLC method for determination of paeoniflorin-metabolizing activity of intestinal bacteria in rat faeces. Chem. Pharm. Bull. 50: 1233-1237
14. Heikal, O. A., Akao, T., Takeda, S., Hattori, M. (1997) Pharmacokinetic study of paeonimetabolin I, a major metabolite of paeoniflorin from paeony roots. Biol. Pharm. Bull. 20: 517-521
15. Ishihara, M., Homma, M., Kuno, E., Watanabe, M., Kohda, Y. (2002) Combination use of Kampo-medicines and drugs affecting intestinal bacterial flora. Yakugaku Zasshi 122: 695-701
16. Kanaoka, M., Yano, S., Kato, H., Nakanishi, K., Yoshizaki, M. (1984) Studies on the enzyme immunoassay of bio-active constituents contained in oriental medicinal drugs III. Enzyme immunoassay of paeoniflorin, a constituent of Chinese Paeony root. Chem. Pharm. Bull. 32: 1461-1466
17. Katsura, T. (1995) The remarkable effect of Kanzo-to and Shakuyakukanzo-to in the treatment of acute abdominal pain. Jpn. J. Orient. Med. 46: 293-299
18. Kobashi, K., Akao, T., Hattori, M., Namba, T. (1992) Metabolism of drugs by intestinal bacteria. Bifidobacteria Microflora 11: 9-23
19. Kobayashi, M., Ueda, C., Aoki, S., Tajima, K., Tanaka, N., Yamahara, J. (1990) Anticholinergic action of Paeony root and its active constituents. Yakugaku Zasshi 110: 964-968
20. Mager, H., Goller, G. (1998) Resampling methods in sparse sampling situations in preclinical pharmacokinetic studies. J. Pharm. Sci. 87: 372-378
21. Meselhy, M. R., Hattori, M. (2000) Recent studies on the paeony root and a bioactive constituent, paeoniflorin. Curr. Top. Phytochem. 4: 1-19
22. Nedelman, J. R., Gibiansky, E., Lau, D. T. W. (1995) Applying Bailer's method for AUC confidence intervals to sparse sampling. Pharm. Res. 12: 124-128
23. Nishimura, N., Naora, K., Hirano, H., Iwamoto, K. (1998) Effects of Sho-saiko-to on the pharmacokinetics and pharmacodynamics of tolbutamide in rats. J. Pharm. Pharmacol. 50: 231-236
24. Oguri, T., Kosakai, N. (1979) Comparison of the antibacterial activity of ticarcillin with other antibacterial agents. Jpn. J. Antibiot. 32: 729-743
25. Rowland, M., Tozer, T. N. (1995) Clinical Pharmacokinetics: Concepts and Applications, 3rd edn. Lea & Febiger, Philadelphia.
26. Shu, Y. Z., Hattori, M., Akao, T., Kobashi, K., Kagei, K., Fukuyama, K., Tsukihara, T., Namba, T. (1987) Metabolism of paeoniflorin and related compounds by human intestinal bacteria. II. Structures of 7S- and 7R-paeonimetabolines I and II formed by Bacteroides fragilis and Lactobacillus brevis. Chem. Pharm. Bull. 35: 3726-3733
27. Soll, A. H. (1996) Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA 275: 622-629
28. Sugishita, E., Amagaya, S., Ogihara, Y. (1984) Studies on the combination of Glycyrrhizae Radix in Shakuyakukanzo-To. J. Pharmacobiodyn. 7: 427-435
29. Takeda, S., Isono, T., Wakui, Y., Matsuzaki, Y., Sasaki, H., Amagaya, S., Maruno, M. (1995) Absorption and excretion of paeoniflorin in rats. J. Pharm. Pharmacol. 47: 1036-1040
30. Yamaguchi, T., Goto, H., Ishida, G., Miyagawa, I., Fukuda, K., Hirakawa, S. (1982) Clinical experience of Choreito and Shakuyakukanzoto to ureteral stone. Nishinihon J. Urol. 44: 337-341